AONC 📈 American Oncology Network - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •

AONC: Lab Testing, Pathology Services, Specialty Pharmacy, Care Management Support

American Oncology Network, Inc., through its subsidiaries, provides oncology services in the United States. The company provides various services to patients, including laboratory services for routine and specialized testing; in-house professional and technical pathology services with complete, accurate and timely pathology reports; in-house specialty pharmacy services with patient education, financial assistance, and 24/7 patient assistance; and care management support services including nutrition guidance. The company was incorporated in 2017 and is based in Fort Myers, Florida. Web URL: https://www.aoncology.com

Additional Sources for AONC Stock

AONC Stock Overview

Market Cap in USD 118m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2021-05-05

AONC Stock Ratings

Growth 5y -70.6%
Fundamental 24.6%
Dividend -
Rel. Strength Industry -505
Analysts -
Fair Price Momentum 4.42 USD
Fair Price DCF 31.30 USD

AONC Dividends

No Dividends Paid

AONC Growth Ratios

Growth Correlation 3m 63.3%
Growth Correlation 12m -52.9%
Growth Correlation 5y -44%
CAGR 5y -18.08%
CAGR/Mean DD 5y -0.57
Sharpe Ratio 12m 0.44
Alpha -22.13
Beta -0.30
Volatility 69.54%
Current Volume 2.1k
Average Volume 20d 4.1k
What is the price of AONC stocks?
As of December 22, 2024, the stock is trading at USD 4.64 with a total of 2,050 shares traded.
Over the past week, the price has changed by +1.75%, over one month by +8.16%, over three months by +28.53% and over the past year by -20.82%.
Is American Oncology Network a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, American Oncology Network is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 24.57 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AONC as of December 2024 is 4.42. This means that AONC is currently overvalued and has a potential downside of -4.74%.
Is AONC a buy, sell or hold?
American Oncology Network has no consensus analysts rating.
What are the forecast for AONC stock price target?
According to ValueRays Forecast Model, AONC American Oncology Network will be worth about 4.8 in December 2025. The stock is currently trading at 4.64. This means that the stock has a potential upside of +2.8%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 4.8 2.8%